Breast cancer in the arctic - Changes over the past decades

International Journal of Circumpolar Health

Volumn 71, Issue 1, 2012, Pages

  Fredslund, Stine Overvad ^a   Bonefeld Jørgensen, Eva Cecilie ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Arctic; Breast cancer; Incidence; Persistent organic pollutants; Risk factors

Indexed keywords

ARCTIC; BREAST TUMOR; FEMALE; HUMAN; INCIDENCE; REVIEW; RISK FACTOR;

ARCTIC REGIONS; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84872901039     PISSN: 12399736     EISSN: 22423982     Source Type: Journal    
DOI: 10.3402/ijch.v71i0.19155     Document Type: Review

References (105)

1. Lanier AP, Blot WJ, Bender TR, Fraumeni JF Jr. Cancer in Alaskan Indians, Eskimos, and Aleuts. J Natl Cancer Inst. 1980;65:1157-9.
2. Nielsen NH, Hansen JP. Breast cancer in Greenland-selected epidemiological, clinical, and histological features. J Cancer Res Clin Oncol. 1980;98:287-99.
3. Friborg JT, Melbye M. Cancer patterns in Inuit populations. Lancet Oncol. 2008;9:892-900.
4. Landslægeembedets Årsberetning [Annual report of the Country Doctor's office]. Nuuk: Government of Greenland; 2011 [cited 2011 Apr 18]. Available from: http://dk.nanoq.gl/Emner/Landsstyre/Departementer/Landslaegeembedet/Udgivelser/Aarsberetning.aspx. [In Danish]
5. U.S. National Institutes of Health, National Cancer Institute, Cancer Statistics. U.S. National Institutes of Health. Breast cancer incidence rates by race. Bethesda: U.S. National Institutes of Health [cited 2011 Nov]. Available from: http://seer.cancer.gov/statfacts/html/breast.html#incidence-mortality
6. Kræftens Bekæmpelse. Statistik om brystkræft. Copenhagen: Kræftens Bekæmpelse; 2010 [cited 2012 May 3]. Available from: http://www.cancer.dk/Hjaelp-viden/kraeftformer/kraeftsygdomme/brystkraeft/statistik-brystkraeft/.[In Danish].
7. Young TK, Bjerregaard P, editors. Health transitions in Arctic populations, part four. Toronto: University of Toronto Press; 2008. p. 308-33 and p. 379-402.
8. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97(6):439-48.
9. Statistics Greenland. Nuuk: Statistics Greenland; 2011. [cited 2012 February 29]. Available from: http://www.stat.gl/.[In Danish]
10. Cutting S, Flanders-Stepans MB. Breastfeeding prevalence among an Alaskan Inupiat Eskimo population. J Perinat Educ. 2001;10:21-30.
11. Hansen TV, Ejlertsen B, Albrechtsen A, Bergsten E, Bjerregaard P, Hansen T, et al. A common Greenlandic Inuit BRCA1 RING domain founder mutation. Breast Cancer Res Treat. 2009;115:69-76.
12. Harboe TL, Eiberg H, Kern P, Ejlertsen B, Nedergaard L, Timmermans-Wielenga V, et al. A high frequent BRCA1 founder mutation identified in the Greenlandic population. Fam Cancer. 2009;8:413-9.
13. Newcomb PA, Lantz PM. Recent trends in breast cancer incidence, mortality, and mammography. Breast Cancer Res Treat. 1993;28:97-106.
14. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl 8): S4-66.
15. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002;38:99-166.
16. Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, et al. Breast cancer incidence among American Indian and Alaska Native women: US, 1999-2004. Cancer. 2008;113(Suppl 5):1191-202.
17. The Association of the Nordic Cancer Registries. The NORDCAN project. The Association of the Nordic Cancer Registries; 2009 [cited 2012 Aug 1]. Available from: http://www-dep.iarc.fr/NORDCAN/DK/frame.asp
18. Canadian Cancer Society. General cancer statistics at a glance. Toronto: Canadian Cancer Society; 2012. [cited 2012 May 8] Available from: http://www.cancer.ca/Canada-wide/About%20cancer/Cancer%20statistics/Stats%20at%20a%20glance/General%20cancer%20stats.aspx?sc-lang=en#ixzz1JofN4kJQ
19. Louchini R, Beaupre M. Cancer incidence and mortality among Aboriginal people living on reserves and northern villages in Quebec, 1988-2004. Int J Circumpolar Health. 2008;67:445-51.
20. Vaktskjold A, Ungurjanu TN, Klestsjinov NM. Cancer incidence in the Nenetskij Avtonomnyj Okrug, Arctic Russia. Int J Circumpolar Health. 2008;67:433-44.
21. Garin AM. Breast cancer in Russia. Breast Cancer. 2004;11:7-9.
22. Kelly J, Lanier A, Santos M, Healey S, Louchini R, Friborg J, et al. Cancer among the circumpolar Inuit, 1989-2003. II. Patterns and trends. Int J Circumpolar Health. 2008;67: 408-20.
23. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States xplained by well-established risk factors. J Natl Cancer Inst. 1995;87:1681-5.
24. Peeters PH, Verbeek AL, Krol A, Matthyssen MM, deWaard F. Age at menarche and breast cancer risk in nulliparous women. Breast Cancer Res Treat. 1995;33:55-61.
25. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev. 1993;15:7-16.
26. Chang-Claude J, Andrieu N, Rookus M, Brohet R, Antoniou AC, Peock S, et al. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev. 2007; 16:740-6.
27. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2(3):133-40.
28. Tavassoli FA. The influence of endogenous and exogenous reproductive hormones on the mammary glands with emphasis on experimental studies in rhesus monkeys. Verh Dtsch Ges Pathol. 1997;81:514-20.
29. Becker-Christensen FG. Growth in Greenland: development of body proportions and menarcheal age in Greenlandic children. Int J Circumpolar Health. 2003;62:284-95.
30. Toft G, Axmon A, Lindh CH, Giwercman A, Bonde JP. Menstrual cycle characteristics in European and Inuit women exposed to persistent organochlorine pollutants. Hum Reprod. 2008;23:193-200.
31. Mellon S, Berry-Bobovski L, Gold R, Levin N, Tainsky MA. Concerns and recommendations regarding inherited cancer risk: the perspectives of survivors and female relatives. J Cancer Educ. 2007;22:168-73.
32. Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Krüger T, et al. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health. 2011;10:88.
33. Miyoshi Y, Noguchi S. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women. Biomed Pharmacother. 2003;57:471-81.
34. Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, et al. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8:41-4.
35. Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA. Environmental pollutants and breast cancer: epidemiologic studies. Cancer. 2007;109(Suppl 12):2667-711.
36. Chen Y, Pei J. Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis. Breast Cancer Res Treat. 2010;122:471-81.
37. Ma X, Qi X, Chen C, Lin H, Xiong H, Li Y, et al. Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls. Breast Cancer Res Treat. 2010;122:495-501.
38. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239-48.
39. Guengerich FP. Cytochromes P450, drugs, and diseases. Mol Interv. 2003;3:194-204.
40. Yadav S, Singhal NK, Singh V, Rastogi N, Srivastava PK, Singh MP. Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women. Dis Markers. 2009;27:203-10.
41. Yao L, Fang F, Wu Q, Zhong Y, Yu L. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects. Breast Cancer Res Treat. 2010;122:237-42.
42. Economopoulos KP, Sergentanis TN. Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent metaanalysis. Breast Cancer Res Treat. 2010;124:293-4.
43. Maclennan M, Ma DW. Role of dietary fatty acids in mammary gland development and breast cancer. Breast Cancer Res. 2010;12:211.
44. Young TK, Bjerregaard P, Dewailly E, Risica PM, Jørgensen ME, Ebbesson SE. Prevalence of obesity and its metabolic correlates among the circumpolar inuit in 3 countries. Am J Public Health. 2007;97:691-5.
45. Lautenbach A, Budde A, Wrann CD, Teichmann B, Vieten G, Karl T, et al. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer. 2009;61:484-91.
46. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166:2395-402.
47. Barnard RJ, Gonzalez JH, Liva ME, Ngo TH. Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro. Nutr Cancer. 2006;55:28-34.
48. Goodman MT, Nomura AM, Wilkens LR, Hankin J. The association of diet, obesity, and breast cancer in Hawaii. Cancer Epidemiol Biomarkers Prev. 1992;1:269-75.
49. Haslam SZ, Schwartz RC. Is there a link between a high-fat diet during puberty and breast cancer risk? Womens Health (Lond Engl). 2011;7:1-3.
50. Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, et al. Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer. 2007;109(Suppl 12):2627-34.
51. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst. 1994;86:1403-8.
52. Theroux R. Breast cancer menopause: do weight and exercise affect risk? Nurse Women's. Health. 2007;11:319-21.
53. Suzuki R, Iwasaki M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, et al. Leisure-time physical activity and breast cancer risk by hormone receptor status: effective life periods and exercise intensity. Cancer Causes Control. 2010;21: 1787-98.
54. Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst. 2005;97:1671-9.
55. Hirose K, Hamajima N, Takezaki T, Miura S, Tajima K. Physical exercise reduces risk of breast cancer in Japanese women. Cancer Sci. 2003;94:193-9.
56. Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, et al. Alcohol drinking and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2007; 37:568-74.
57. Boyle P, Boffetta P. Alcohol consumption and breast cancer risk. Breast Cancer Res. 2009;11(Suppl 3):S3.
58. Beasley JM, Coronado GD, Livaudais J, Angeles-Llerenas A, Ortega-Olvera C, Romieu I, et al. Alcohol and risk of breast cancer in Mexican women. Cancer Causes Control. 2010; 21:863-70.
59. Kawai M, Minami Y, Kakizaki M, Kakugawa Y, Nishino Y, Fukao A, et al. Alcohol consumption and breast cancer risk in Japanese women: The Miyagi Cohort Study. Breast Cancer Res Treat. 2011;128:817-25.
60. Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study. J Natl Cancer Inst. 2010;102:1422-31.
61. Dennis J, Ghadirian P, Little J, Lubinski J, Gronwald J, Kim-Sing C, et al. Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. Breast. 2010;19:479-83.
62. Danmarks Statistik, NYT Fra Danmarks Statistik Nr. 309, 2. Juli 2010. Copenhagen: Danmarks Statistik; 2010, [cited 2012 Aug 1]. Available from: http://www.dst.dk/da/statistik/nyt/relateret.aspx?psi=1168
63. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 1990;162:502-14.
64. Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet. 2002;360:1044-9.
65. John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev. 1993;15:157-62.
66. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982;2:5-73.
67. Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB. Cigarette smoking and the incidence of breast cancer. Arch Intern Med. 2011;171:125-33.
68. Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, et al. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the nurses' health study. Cancer Res. 1998;58:667-71.
69. Albrektsen G, Heuch I, Hansen S, Kvåle G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer. 2005;92: 167-75.
70. Medina D. Breast cancer: the protective effect of pregnancy. Clin Cancer Res. 2004;10(1 Pt 2):380S-4S.
71. Thalib L, Doi SA, Hall P. Multiple births and breast cancer prognosis: a population based study. Eur J Epidemiol. 2005;20:613-7.
72. Albrektsen G, Heuch I, Kvåle G. The short-term and longterm effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer. 1995;72:480-4.
73. Pathak DR. Dual effect of first full term pregnancy on breast cancer risk: empirical evidence and postulated underlying biology. Cancer Causes Control. 2002;13:295-8.
74. Archibald L. Teenage pregnancy in Inuit Communities: issues and perspectives. Ottawa: Pauktuutit Inuit Women's Association; 2004 [cited 2012 Aug 2]. Available from: http://pauktuutit.ca/pdf/publications/pauktuutit/TeenPregnancy-e.pdf
75. Jordan I, Hebestreit A, Swai B, Krawinkel MB. Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania. Breast Cancer Res Treat. 2010 Nov 20. [Epub ahead of print]. Doi: 10.1007/s10549-010-1255-7
76. Hildes JA, Schaefer O. The changing picture of neoplastic disease in the western and central Canadian Arctic (1950-1980). Can Med Assoc J. 1984;130:25-32.
77. Stuebe AM, Willett WC, Xue F, Michels KB. Lactation and incidence of premenopausal breast cancer: a longitudinal study. Arch Intern Med. 2009;169:1364-71.
78. Xu X, Dailey AB, Peoples-Sheps M, Talbott EO, Li N, Roth J. Birth weight as a risk factor for breast cancer: a metaanalysis of 18 epidemiological studies. J Womens Health (Larchmt). 2009;18:1169-78.
79. Deardorff J, Ekwaru JP, Kushi LH, Ellis BJ, Greenspan LC, Mirabedi A, et al. Father absence, body mass index, and pubertal timing in girls: differential effects by family income and ethnicity. J Adolesc Health. 2011;48:441-7.
80. Buyken AE, Karaolis-Danckert N, Remer T. Association of prepubertal body composition in healthy girls and boys with the timing of early and late pubertal markers. Am J Clin Nutr. 2009;89:221-30.
81. Romundstad PR, Vatten LJ, Nilsen TI, Holmen TL, Hsieh CC, Trichopoulos D, et al. Birth size in relation to age at menarche and adolescent body size: implications for breast cancer risk. Int J Cancer. 2003;105:400-3.
82. Lujan Irastorza JE, Garcia Rodriguez F, Figueroa Preciado G, Hernandez Marin I, Ayala AR. [Early menarche as a risk factor of breast cancer]. Ginecol Obstet Mex. 2006;74: 568-72. [In Spanish]
83. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514-27.
84. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer. 2010;46:2196-205.
85. Welsh J. Vitamin D metabolism in mammary gland and breast cancer. Mol Cell Endocrinol. 2011;347:55-60.
86. Qureshi SA, Couto E, Hilsen M, Hofvind S, Wu AH, Ursin G. Mammographic density and intake of selected nutrients and vitamins in Norwegian women. Nutr Cancer. 2011; 63:1011-20.
87. Gueli N, Verrusio W, Linguanti A, Di Maio F, Martinez A, Marigliano B, et al. Vitamin D: drug of the future. A new therapeutic approach. Arch Gerontol Geriatr. 2012;54:222-7.
88. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010; 171:903-8.
89. Grant WB, Juzeniene A, Lagunova Z, Porojnicu AC, Moan JE. Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer. Int J Cancer. 2011;128:2249-50.
90. El Hayek J, Egeland G, Weiler H. Vitamin D status of Inuit preschoolers reflects season and vitamin D intake. J Nutr. 2010;140:1839-45.
91. Bonefeld-Jorgensen EC. Biomonitoring in Greenland: human biomarkers of exposure and effects - a short review. Rural Remote Health. 2010;10:1362.
92. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007;99:366-4.
93. Donaldson SG, Van Oostdam J, Tikhonov C, Feeley M, Armstrong B, Ayotte P, et al. Environmental contaminants and human health in the Canadian Arctic. Sci Total Environ. 2010;408:5165-234.
94. Long M, Bossi R, Bonefeld-Jørgensen EC. Level and temporal trend of perfluoroalkyl acids in Greenlandic Inuit. Int J Circumpolar Health. 2012;71:17998.
95. Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Mølbak K, Weihe P, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012;307:391-7.
96. Maras M, Vanparys C, Muylle F, Robbens J, Berger U, Barber JL, et al. Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation. Environ Health Perspect. 2006;114:100-5.
97. Gilman A, Ayotte P, Dewailly E, Dudarev A, Bonefeld-Jørgensen EC, Muckle G, et al. Chapter 8. Public Health and the Effects of Contaminants. In: The International Arctic Monitoring and Assessment Report (AMAP), Human health in the Arctic 2009. Oslo: Arctic Monitoring and Assessment Programme (AMAP); 2009. p. 143-90. [cited 2012 Apr 15]Available from: http://www.amap.no
98. Golden R, Kimbrough R. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003. Crit Rev Toxicol. 2009;39:299-331.
99. Fenton SE. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology. 2006;147(Suppl 6):S18-24.
100. Schreer I. Dense breast tissue as an important risk factor for breast cancer and implications for early detection. Breast Care (Basel). 2009;4:89-92.
101. Roubidoux MA, Kaur JS, Griffith KA, Stillwater B, Novotny P, Sloan J. Relationship of mammographic parenchymal patterns to breast cancer risk factors and smoking in Alaska Native women. Cancer Epidemiol Biomarkers Prev. 2003; 12:1081-6.
102. Fenton SE, Hamm JT, Birnbaum LS, Youngblood GL. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci. 2002; 67:63-74.
103. Mulero-Navarro S, Pozo-Guisado E, Perez-Mancera PA, Alvarez-Barrientos A, Catalina-Fernandez I, Hernandez-Nieto E, et al. Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model. J Biol Chem. 2005;280(31):28731-41.
104. Yoshizawa K, Heatherly A, Malarkey DE, Walker NJ, Nyska A. A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF. Toxicol Pathol. 2007;35:865-79.
105. Hilakivi-Clarke L, de Assis S. Fetal origins of breast cancer. Trends Endocrinol Metab. 2006;17:340-8.